Steve Demas

Steve Demas is the Director of the Neuromuscular Clinical Trial Delivery Unit, bringing over 30 years of experience in pharmaceuticals and biotechnology. They have held various leadership roles, including Associate Director at Biogen, where they currently manage early-stage clinical programs related to ALS and MS. Previously, Demas worked at notable companies such as Bayer and Medicenna Therapeutics, overseeing clinical operations and project management. They earned a Bachelor’s Degree in Pharmacology from the University of Toronto.